期刊文献+

胃癌CD133阳性细胞的纯化及其生物学特性研究 被引量:10

Study on Biological Characteristics of CD133 Positive Population in Gastric Cancer Cells by Magnetic Activated Cell Sorting In Vitro
原文传递
导出
摘要 目的检测人胃癌KATO-Ⅲ、SGC7901、AGS及MKN-45细胞株中CD133基因及蛋白的表达,研究CD133阳性(CD133+)细胞与CD133阴性(CD133-)细胞的生物学特性的差异。方法采用半定量聚合酶链反应及免疫蛋白印迹法分别检测KATO-Ⅲ、SGC7901、AGS及MKN-45细胞株中CD133基因和蛋白的表达;免疫磁珠细胞技术将KATO-Ⅲ细胞株中CD133+和CD133-细胞分离纯化,对比两者生长形态特点、体外增殖能力及分化能力的差异;采用CCK-8法分析CD133+和CD133-细胞对不同浓度(0.05、0.10、0.20、0.50、1.00mg/ml)化疗药物5-氟尿嘧啶(5-FU)敏感性的差别。结果 KATO-Ⅲ细胞中CD133基因及蛋白表达量均明显高于SGC7901、AGS及MKN-45细胞(P<0.05)。CD133+细胞在无血清培养基中呈球形克隆悬浮生长,相比CD133-细胞具有更强的体外增殖能力及潜在分化能力。5-FU耐药性实验中,CD133+细胞在0.50mg/ml浓度下的抑制率较CD133-细胞明显降低(P<0.05),但其他浓度时二者比较差异无统计学意义(P>0.05)。结论人胃癌细胞株KATO-Ⅲ中的CD133+细胞具有一定增殖、分化及耐药潜能,CD133可作为胃肿瘤起始细胞亚群的表面标志之一。 Objective To detect the expressions of CD133 in four gastric cancer cell lines(KATO-Ⅲ,SGC7901,AGS,and MKN-45) and investigate the different biological characteristics of CD133 positive(CD133+) cells and CD133 negative(CD133-) cells in the KATO-Ⅲ cell lines. Methods The CD133 gene and protein expressions of four gastric cancer cell lines were evaluated by semi-quantitative RT-PCR and Western blot,respectively.CD133+ cells in KATO-Ⅲ cell lines were isolated by magnetic activated cell sorting(MACS) and examined in morphology,growth characteristics,proliferation,and differentiation in vitro.The sensitivity of different concentrations(0.05,0.10,0.20,0.50,and 1.00 mg/ml) 5-fluoropyrimidinedione(5-FU) were contrasted by drug sensitivity testing in vitro(Cell Counting Kit 8-assay) between CD133+ cells and CD133-cells. Results The expressions of CD133 gene and protein in the KATO-Ⅲ cell lines were significantly higher than those in the other three cell lines(P〈0.05).CD133+ cells produced spheroid colonies in serum-free medium culture and were stronger abilities of proliferation and differentiation than those of CD133-cells in vitro.The inhibitor rate of the CD133+ cells at concentration of 0.50 mg/ml was lower than that of CD133-cells(P〈0.05). Conclusions Cell population with CD133+ in the KATO-Ⅲ cell lines have strong ability of cloning,better capability of proliferation and differentiation,as well as anticancer drug resistance to 5-FU.CD133 can be applied as one of surface markers for the detection to gastric cancer initiator cells.
出处 《中国普外基础与临床杂志》 CAS 2011年第12期1265-1270,共6页 Chinese Journal of Bases and Clinics In General Surgery
基金 上海交通大学医学院科研基金赞助(项目编号:2007XJ032 2009XJ21037) 上海市科委基金赞助(项目编号:09411962300)~~
关键词 肿瘤起始细胞 CD133 胃癌 LU Rui-qi1,WU Ju-gang1,ZHOU Guo-cai1,2,JIANG Hai-guang1,2,NI Xiao-chun1,YU Ji-wei1,JIANG Bo-jian1.1.Department of General Surgery,No.3 People’s Hospital,Shanghai Jiao-Tong University School of Medicine,Shanghai 201900,China 2.Graduate School,Bengbu Medical College,Bengbu 233030,Anhui Province,ChinaLU Rui-qi1,WU Ju-gang1,ZHOU Guo-cai1,2,JIANG Hai-guang1,2,NI Xiao-chun1,YU Ji-wei1,JIANG Bo-jian1.1.Department of General Surgery,No.3 People’s Hospital,Shanghai Jiao-Tong University School of Medicine,Shanghai 201900,China 2.Graduate School,Bengbu Medical College,Bengbu 233030,Anhui Province,China Tumor initiator cell CD133 Gastric cancer
  • 相关文献

参考文献21

  • 1Bonnet D,Dick JE.Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell[J].Nat Med,1997,3(7):730-737.
  • 2Wulf GG,Wang RY,Kuehnle 1,et al.A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemia[J].Blood,2001,98(4):1166-1173.
  • 3Pérez Castillo A,Aguilar-Morante D,Morales-García JA,et al.Cancer stem cells and brain tumors[J].Clin Transl Oncol,2008,10(5):262-267.
  • 4Field M,Alvarez A,Bushnev S,et al.Embryonic stem cell markers distinguishing cancer stem cells from normal human neuronal stem cell populations in malignant glioma patients[J].Clin Neurosurg,2010,57:151-159.
  • 5Yu SC,Ping YF,Yi L,et al.Isolation and characterization of cancer stem cells from a human glioblastoma cell line U87[J].Cancer Lett,2008,265(1):124-134.
  • 6Miraglia S,Godfrey W,Yin AH,et al.A novel five-transmembrane hematopoietic stem cell antigen:isolation,characterization,and molecular cloning[J].Blood,1997,90(12):5013-5021.
  • 7Kang MK,Kang SK.Tumorigenesis of chemotherapeutic drug-resistant cancer stem-like cells in brain glioma[J].Stem Cells Dev,2007,16(5):837-847.
  • 8O'Brien CA,Pollett A,Gallinger S,et al.A human colon cancer cell capable of initiating tumour growth in immunodeficient mice[J].Nature,2007,445(7123):106-110.
  • 9Rappa G,Fodstad O,Lorico A.The stem cell-associated antigen CD133 (prominin-1) is a molecular therapeutic target for metastatic melanoma[J].Stem Cells,2008,26 (12):3008-3017.
  • 10王晓辉,李非.胰腺癌干细胞的研究进展[J].中国普外基础与临床杂志,2011,18(9):931-935. 被引量:3

二级参考文献40

  • 1Monika Olempska,Patricia Alice Eisenach,Ole Ammerpohl,Hendrik Ungefroren,Fred Fandrich,Holger Kalthoff.Detection of tumor stem cell markers in pancreatic carcinoma cell lines[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):92-97. 被引量:69
  • 2朱军华,陶凯雄,王国斌.TNF-α对肝癌细胞VEGF和MMP-9表达的影响[J].中国普外基础与临床杂志,2005,12(4):384-389. 被引量:15
  • 3Hanahan D, Weinberg RA. The hallmarks of cancer [J]. Cell, 2000; 100(1): 57
  • 4D'Amour KA, Gage FH. Are somatic stem cells pluripotent or lineage-restrieted? [J]. Nat Med, 2002; 8(3):213
  • 5Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells [J]. Nature, 2004; 432(7015): 396
  • 6Lapidot T, Sirard C, Vormoor J, et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice [J]. Nature, 1994; 367(6464):645
  • 7Park CH, Bergsagel DE, McCulloch EA. Mouse rnyeloma tumor stem cells: a primary cell culture assay [J]. J Natl Cancer Inst, 1971, 46(2): 411
  • 8O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating turnout growth in immunodeficient mice [J]. Nature, 2006; 445(7123):106
  • 9Collins AT, Berry PA, Hyde C, et al. Prospective identifica tion of tumorigenic prostate cancer stem cells [J]. Cancer Res, 2005; 65(23) : 10946
  • 10Suetsugu A, Nagaki M, Aoki H, et al. Characterization of CD133^+ hepatocellular carcinoma cells as cancer stem/progenitor cells [J]. Biochem Biophys Res Commun, 2006, 351(4) 820

共引文献11

同被引文献97

  • 1Monika Olempska,Patricia Alice Eisenach,Ole Ammerpohl,Hendrik Ungefroren,Fred Fandrich,Holger Kalthoff.Detection of tumor stem cell markers in pancreatic carcinoma cell lines[J].Hepatobiliary & Pancreatic Diseases International,2007,6(1):92-97. 被引量:69
  • 2许德晖,黄辰,刘利英,宋土生.高效siRNA设计的研究进展[J].遗传,2006,28(11):1457-1461. 被引量:21
  • 3Forman D, Burley VJ. Gastric cancer: global pattern of the disease and an overview of environmental risk factors [ J]. Best Pract Res Clin Gastroenterol, 2006, 20(4) : 633-649.
  • 4Zheng YH, Zhou MT, Ye A, et al. The conformation change of Bcl-2 is involved in arsenic trioxide-induced apoptosis and inhibi-tion of proliferation in SGC7901 human gastric cancer cells [ J ]. World J Surg Oncol, 2010, 8: 31.
  • 5Yin AH, Miraglia S, Zanjaui ED, et al. ACl33, a novel marker for human hematopoietic stem and progenitor cells [ J ]. Blood, 1997, 90(12) : 5002-5012.
  • 6Peichev M , Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34( + ) cells identifies a popu- lation of functional endothelial precursors [ J ]. Blood, 2000, 95 (3) : 952-958.
  • 7Dean M, Fojo T, Bates S. Tumour stem cells and drug resistance [J]. Nat Rev Cancer, 2005, 5(4) : 275-284.
  • 8Koshiji M, To KK, Hammer S, et al. HIF-lalpha induces genetic instability by transcriptionally downregulating MutSalpha expression [J]. Mol Cell, 2005, 17(6) : 793-803.
  • 9Bunting KD, Zhou S, Lu T, et al. Enforced P-glycoprotein pump function in murine bone marrow ceils results in expansion of side population stem cells in vitro and repopulating cells in vivo [ J ].Blood, 2000, 96(3): 902-909.
  • 10Shackleton M, Qnintana E, Fearon ER, et al. Heterogeneity in cancer: cancer stem ceils versus clonal evolution [ J ]. Cell, 2009, 138(5) : 822-829.

引证文献10

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部